G. Steven Burrill

Welcome from the CEO

Flash required to view this video. Download the latest version here

 G. Steven Burrill 

Podcast

Hear 
G. Steven Burrill's vision of healthcare in the year 2020 in a special podcast from The Journal of Life Sciences.
Hear the podcast 

Burrill Conferences

Sponsors

Presented withPlatinumGoldSilverBronzeEvent Partners

Life Sciences Conferences

The Burrill China Life Sciences Meeting

Agenda

Preliminary Agenda

June 16, 2008

7:30 a.m. – 8:00 a.m. 

Breakfast & Registration

                                                                                                                                                                    

8:00 a.m. – 8:45 a.m.

Keynote Presentation:  Biotech State of the Industry – A Global Look

G. Steven Burrill, CEO, Burrill & Company

 

8:45 a.m. – 9:00 a.m. 

China/San Diego/California - A Global Biotech Cluster

Joe Panetta, President & CEO, BIOCOM

 

9:00 a.m. – 9:15 a.m. 

Break

                                                                             

9:15 a.m. – 10:30 a.m.

From Idea to IPO: Pathfinders in China Life Sciences

- Dr. Jian Han, PhD, Principal Investigator, Hudson Alpha Institute for Biotechnology,

  Special Advisor, Greater China, Burrill & Company

- Edward Hu, COO, WuXi PharmaTech

- Jie Liu, EVP, International Sales & Marketing, Mindray Medical International

- Jimmy Wei, PhD, VP, Hutchinson MediPharma

Moderated by: Dr. Marietta Wu, PhD, Director , Burrill & Company

 

10:30 a.m. – 11:45 a.m.                 

Partnering in China

 - Martyn Greenacre, Chairman, BMP Sunstone   

- Dr. Fang Hu, PhD, CEO, Shanghai Sunway Biotech  

- Huacheng Wei, Chairman, Beijing Pharmaceutical Group 

- Barbara Yanni, VP & Chief Licensing Officer, Global External Research and Licensing, Merck

Moderated by: Benjamin Chen, PhD, Managing Director, Burrill & Company

                            

Networking Lunch

11:45 a.m. – 12:45 p.m.                                               

 

12:45 p.m. – 1:45 p.m.    

Bridging China to the U.S.  

- Greg Horowitt, Executive Director, Global Connect

- Dr. Jason Jin, PhD, EVP, ShanghaiBio Corp.

- Xuehai Tan, PhD, President & CEO, HD Bioscience

- Dr.Wei -Wei Zhang, President & CEO, Acrotics Corporation

- James Zhu, PhD, Partner, China, Perkins Coie

Moderated by: Benjamin Chen, PhD, Managing Director, Burrill & Company

Jack Florio, VP, Tech Coast Angels &  Senior Advisor, Cabrillo Advisors

 

1:45 p.m. – 2:45 p.m.

Financing Chinese Life Sciences Companies   

- Rachel Gong, PhD, Morningside Ventures

- Dr. James Li, Partner, Kleiner Perkins Caufield & Byers

- Dr. Anthony Sun, Principal, Aisling Capital

- Michael Yang, Managing Director, Greater China and Asia, NYSE  Euronext

- Dr. Chen Yu, Partner, Vivo Ventures

Moderated by:  Ann Hanham, PhD, Managing Director, Burrill & Company

Greg B. Scott, President, ChinaBio Accelerator  & President, Life Science Angels

                                                        

2:45 p.m. – 3:00 p.m.                                                                   

Break

 

3:00 p.m. – 3:45 p.m. 

Year 2020 – China/India: A Comparison                                     

- Futurist who can find what China will look like in 2020:

Dr. Hongguang Wang, PhD, Director, China National Center for Biotech Development

- Futurist who can find what India will look like in 2020:

Rashmi Barbhaiya, PhD, CEO & Managing Director, Advinus Therapeutics

Moderated by: G. Steven Burrill, CEO, Burrill & Company

 

3:45 p.m. – 4:00 p.m. 

Closing Remarks

G. Steven Burrill, CEO, Burrill & Company

 

4:00 p.m. – 5:30 p.m. 

Networking Reception

Sponsored by:  Wilson Sonsini Goodrich & Rosati